These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35792120)

  • 1. Genetic Analysis of HIV-1
    Love M; Samora L; Barker D; Zukosky P; Kummet N; Ahmad A; Bernhardt D; Tripathi M; Klotz S; Ahmad N
    Curr HIV Res; 2022; 20(4):309-320. PubMed ID: 35792120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of HIV-1 Envelope V3 Region Sequences from Virologically Controlled HIV-Infected Older Patients on Long Term Antiretroviral Therapy.
    Behrens NE; Love M; Bandlamuri M; Bernhardt D; Wertheimer A; Klotz SA; Ahmad N
    AIDS Res Hum Retroviruses; 2021 Mar; 37(3):233-245. PubMed ID: 33287636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmission.
    Yedavalli VR; Chappey C; Ahmad N
    J Virol; 1998 Aug; 72(8):6937-43. PubMed ID: 9658150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low conservation of functional domains of HIV type 1 vif and vpr genes in infected mothers correlates with lack of vertical transmission.
    Yedavalli VR; Ahmad N
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):911-23. PubMed ID: 11461677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection.
    Zhang L; Huang Y; Yuan H; Tuttleton S; Ho DD
    Virology; 1997 Feb; 228(2):340-9. PubMed ID: 9123841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of the HIV-1 gag nucleocapsid gene associated with vertical transmission.
    Wellensiek BP; Sundaravaradan V; Ramakrishnan R; Ahmad N
    Retrovirology; 2006 Apr; 3():21. PubMed ID: 16600029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma.
    Wang B; Ge YC; Palasanthiran P; Xiang SH; Ziegler J; Dwyer DE; Randle C; Dowton D; Cunningham A; Saksena NK
    Virology; 1996 Sep; 223(1):224-32. PubMed ID: 8806556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An HIV-1 infected long-term non-progressor (LTNP): molecular analysis of HIV-1 strains in the vpr and nef genes.
    Saksena NK; Ge YC; Wang B; Xiang SH; Dwyer DE; Randle C; Palasanthiran P; Ziegler J; Cunningham AL
    Ann Acad Med Singap; 1996 Nov; 25(6):848-54. PubMed ID: 9055015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes.
    Srinivasan A; Ayyavoo V; Mahalingam S; Kannan A; Boyd A; Datta D; Kalyanaraman VS; Cristillo A; Collman RG; Morellet N; Sawaya BE; Murali R
    Virol J; 2008 Aug; 5():99. PubMed ID: 18721481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Vpr Genetic Variations between Chinese Major Circulating Recombinants CRF01_AE and CRF07_BC.
    Du L; Wang L; Yu T; Xin R; Meng Z
    Curr HIV Res; 2020; 18(3):165-171. PubMed ID: 32096745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells.
    de Silva S; Planelles V; Wu L
    PLoS One; 2012; 7(5):e35385. PubMed ID: 22570689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vpr is preferentially targeted by CTL during HIV-1 infection.
    Altfeld M; Addo MM; Eldridge RL; Yu XG; Thomas S; Khatri A; Strick D; Phillips MN; Cohen GB; Islam SA; Kalams SA; Brander C; Goulder PJ; Rosenberg ES; Walker BD;
    J Immunol; 2001 Sep; 167(5):2743-52. PubMed ID: 11509618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.
    Connor RI; Chen BK; Choe S; Landau NR
    Virology; 1995 Feb; 206(2):935-44. PubMed ID: 7531918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects.
    Roff SR; Sanou MP; Rathore MH; Levy JA; Yamamoto JK
    Hum Vaccin Immunother; 2015; 11(6):1540-56. PubMed ID: 25844718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.
    Shen A; Siliciano JD; Pierson TC; Buck CB; Siliciano RF
    Virology; 2000 Dec; 278(1):227-33. PubMed ID: 11112497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of the HIV type 1 vpr gene in infected Chinese former blood/plasma donors at different stages of diseases.
    Shen C; Gupta P; Wu H; Chen X; Huang X; Zhou Y; Chen Y
    AIDS Res Hum Retroviruses; 2008 Apr; 24(4):661-6. PubMed ID: 18366311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
    Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
    J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and functional characterization of human immunodeficiency virus type 1 VprC variants from north India: presence of unique recombinants with mosaic genomes from B, C and D subtypes within the open reading frame of Vpr.
    Bano AS; Sood V; Neogi U; Goel N; Kuttiat VS; Wanchu A; Banerjea AC
    J Gen Virol; 2009 Nov; 90(Pt 11):2768-2776. PubMed ID: 19605589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations.
    Fourati S; Malet I; Guenzel CA; Soulie C; Maidou-Peindara P; Morand-Joubert L; Wirden M; Sayon S; Peytavin G; Simon A; Katlama C; Benichou S; Calvez V; Marcelin AG
    Antiviral Res; 2012 Jan; 93(1):167-74. PubMed ID: 22138483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.